CUSIP 63937X202COMNAVBQQ4 2025
19 filings · latest Feb 5, 2024
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ancora Advisors LLC | 100 | $0 |
| 2 | Front Row Advisors LLC | 280 | $0 |
| 4 | Jul 3, 2023 | Bain Irwin Allen | 13G/A | 4.7% | 4.00M | SEC |
| 5 | Jun 30, 2023 | Bain Irwin Allen | 13G/A | 4.7% | 4.00M | SEC |
| 6 | Jun 16, 2023 | Scott John K Jr. | 13D/A | 52.9% | 30.28M | SEC |
| 7 | Oct 6, 2022 | Bain Irwin Allen | 13G | 6.2% | 1.95M | SEC |
| 8 | Sep 22, 2022 | Scott John K Jr. | 13D/A | 45.7% | 18.77M | SEC |
| 9 | Sep 14, 2022 | Scott John K Jr. | 13D/A | 45.7% | 18.77M | SEC |
| 10 | Sep 12, 2022 | Scott John K Jr. | 13D/A | 45.7% | 18.78M | SEC |
See the full Schedule 13D/13G history for Navidea Biopharmaceuticals Inc.
Unlock full history